Key result
Tricuspid valve surgery was associated with a 95% repair rate, 7.5% hospital mortality, and 77.65% actuarial survival at 48 months.
Observational (n=306)
Tricuspid valve repair is feasible in the vast majority of patients requiring surgery, with acceptable hospital mortality and mid-term survival.
Answers are grounded in this paper and cite their sources.
Supports tricuspid repair feasibility with acceptable mortality in this cohort; leaves open need for RCTs to confirm outcomes.
Contrary to general opinion, the tricuspid valve remains a challenge in terms of its precise diagnosis, indications, and appropriate surgical treatment. This is due to: (1) its relatively low incidence, (2) Its functions in a low pressure system, (3) its close relation to right ventricular function, and (4) it following the dictates of the left-side lesions. In an attempt to elucidate its present status, we reviewed our experience under several categories: (I) Incidence: Among the 1298 valvular patients operated in a period of 5 years (July 1988 to August 1993), 306 (23.6%) native tricuspid valves required surgery. Among the 899 patients with rheumatic etiology, tricuspid involvement was present in 249 (27.7%). (II) Pathology: Excluding other pathologies, organic rheumatic disease was present in 126 (50.6%) and functional regurgitation in 123 (49.4%). However, 45.3% of the organic tricuspids had a dilated annulus, suggesting the existence of organofunctional lesions. (III) Diagnosis: Although two-dimensional echo-Doppler is a reliable diagnostic method, only 41.7% of the organic lesions were diagnosed preoperatively and the remaining at surgery. (IV) Influence of leff-side lesions: In a previous study we showed that the postoperative functional status and cardiac output were primarily related to the results of surgery on the mltral valve, irrespective of whether the tricuspid valve had been correctly or incorrectly repaired or even ignored. (V) Surgical technlques: Because of these reasons, evaluation of the individual superiority is difficult, but all annuloplasties result in a degree of residual stenosis (30% to 70% of patients) that is more pronounced in those with organic lesions. In order to avoid this problem, a re-absorbable “vanishing” De Vega Is suggested in certain cases. (VI) Results: Repair was possible in 291 of 306 (95%) patients. Hospital mortality was 7.5% (23/306) with an actuarial survival of 77.65%± 3.8% at 48 months. (VII) Present day indlcatlons: (1) All organic lesions should undergo a commissurotomy followed by a flexible ring annuloplasty, and (2) functional regurgitations: if severe, flexible ring annuloplasty; if moderate, De Vega; and, if expected to spontaneously regress, reabsorbable De Vega. (J Card Surg 1994;9[Suppl]:242–247)
No takes yet. Share an insight, caveat, or question.
Carlos M.G. Durán (1994) conducted an observational in Tricuspid valve disease requiring surgery (n=306). Tricuspid valve surgery was evaluated on Hospital mortality. Tricuspid valve surgery was associated with a 95% repair rate, 7.5% hospital mortality, and 77.65% actuarial survival at 48 months.
Synapse has enriched 10 related papers. Consider them for comparative context: